Syndecans serve as attachment receptors for human immunodeficiency virus type 1 on macrophages

Journal of Virology

Volumn 75, Issue 19, 2001, Pages 9187-9200

  Saphire, A C S ^a   Bobardt, M D ^a   Zhang, Z ^a   David, G ^a   Gallay, P A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CELL SURFACE PROTEIN; PROTEOHEPARAN SULFATE; SYNDECAN; VIRUS RECEPTOR;

ANTIGEN EXPRESSION; ARTICLE; CELL TYPE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE ADHERENCE; MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR AFFINITY; RECEPTOR BINDING; T LYMPHOCYTE ACTIVATION; VIRUS ADSORPTION; VIRUS TRANSMISSION;

HELA CELLS; HIV INFECTIONS; HIV-1; HUMANS; MACROPHAGES; MEMBRANE GLYCOPROTEINS; PROTEOGLYCANS; RECEPTORS, HIV; SYNDECANS; VIRUS REPLICATION;

EID: 0034848936     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.19.9187-9200.2001     Document Type: Article

References (36)

1. Cerebrospinal fluid abnormalities in patients without AIDS who are seropositive for the human immunod eficiency virus
2. Functions of cell surface heparan sulfate proteoglycans
3. Generation of HIV latency during thymopoiesis
4. Dextran sulfate blocks antibody binding to the principal neutralizing domain of human immunodeficiency virus type 1 without interfering with gp120-CD4 interactions
5. The region of the envelope gene of human immunodeficiency virus type 1 responsible for determination of cell tropism
6. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection
7. Inducible expression of the cell surface heparan sulfate proteoglycan syndecan-2 (fibroglycan) on human activated macrophages can regulate fibroblast growth factor action
8. Early viral brain invasion in iatrogenic human immunodeficiency virus infection
9. Direct ex vivo flow cytometric analysis of human microglial cell CD4 expression: Examination of central nervous system biopsy specimens from HIV-seropositive patients and patients with other neurological disease
10. Neutralization of the human immunodeficiency virus type 1 primary isolate JR-FL by human monoclonal antibodies correlates with antibody binding to the oligomeric form of the envelope glycoprotein complex
11. HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway
12. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells
13. Virus receptors: Binding, adhesion strengthening, and changes in viral structure
14. Macrophage are the principal reservoir and sustain high virus loads in rhesusmacaques after the depletion of CD4+ T cells by a highly pathogenic simian immunodeficiency virus/HIV type 1 chimera (SHIV): Implications for HIV-1 infections of humans
15. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy
16. Human immunodeficiency virus infection and syncytium formation in HeLa cells expressing glycophospholipid-anchored CD4
17. Properties of the K562 cell line derived from a patient with chronic myeloid leukemia
18. Human immunodeficiency virus type 1 attachment to HeLa CD4 cells is CD4 independent and gp120 dependent and requires cell surface heparans
19. HIV. Envelope's letters boxed into shape
20. Virions of primary human immunodeficiency virus type 1 isolates resistant to soluble CD4 (sCD4) neutralization differ in sCD4 binding and glycoprotein gp120 retention from sCD4-sensitive isolates
21. Highly potent RANTES analogues either prevent CCR5-using human immunodeficiency virus type 1 infection in vivo or rapidly select for CXCR4-using variants
22. Selective interactions of polyanions with basic surfaces on human immunodeficiency virus type 1 gp120
23. CD4-negative cells bind human immunodeficiency virus type 1 and efficiently transfer virus to T cells
24. Regulation of anti-HIV-1 activity of RANTES by heparan sulfate proteoglycans
25. Characterization of chemokine receptor utilization of viruses in the latent reservoir for human immunodeficiency virus type 1
26. Increased susceptibility of differentiated mononuclear phagocytes to productive infection with human immunodeficiency virus-1 (HIV-1)
27. Mediation of human immunodeficiency virus type 1 binding by interaction of cell surface heparan sulfate proteoglycans with the V3 region of envelope gp120-gp41
28. Host cyclophilin A mediates HIV-1 attachment to target cells via heparans
29. Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer
30. Early HIV-1 infection and the AIDS dementia complex
31. Susceptibility of human monocytes to HIV type 1 infection in vitro is not dependent on their level of CD4 expression
32. Stimulation of fibroblast growth factor receptor-1 occupancy and signaling by cell surface-associated syndecans and glypican
33. Inhibition of virus attachment to CD4+ target cells is a major mechanism of T cell line-adapted HIV-1 neutralization
34. Cell density-dependent expression of chondroitin sulfate proteoglycan incultured human monocytes
35. The nuclear localization signal of the matrix protein of human immunodeficiency virus type 1 allows the establishment of infection in macrophages and quiescent T lymphocytes
36. Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients